1 | 1 | | 81R1247 PEP-D |
---|
2 | 2 | | By: Anderson H.B. No. 126 |
---|
3 | 3 | | |
---|
4 | 4 | | |
---|
5 | 5 | | A BILL TO BE ENTITLED |
---|
6 | 6 | | AN ACT |
---|
7 | 7 | | relating to the addition of Salvia divinorum and its derivatives |
---|
8 | 8 | | and extracts to Penalty Group 3 of the Texas Controlled Substances |
---|
9 | 9 | | Act. |
---|
10 | 10 | | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
---|
11 | 11 | | SECTION 1. Section 481.104(a), Health and Safety Code, is |
---|
12 | 12 | | amended to read as follows: |
---|
13 | 13 | | (a) Penalty Group 3 consists of: |
---|
14 | 14 | | (1) a material, compound, mixture, or preparation that |
---|
15 | 15 | | contains any quantity of the following substances having a |
---|
16 | 16 | | potential for abuse associated with a stimulant effect on the |
---|
17 | 17 | | central nervous system: |
---|
18 | 18 | | Methylphenidate and its salts; and |
---|
19 | 19 | | Phenmetrazine and its salts; |
---|
20 | 20 | | (2) a material, compound, mixture, or preparation that |
---|
21 | 21 | | contains any quantity of the following substances having a |
---|
22 | 22 | | potential for abuse associated with a depressant effect on the |
---|
23 | 23 | | central nervous system: |
---|
24 | 24 | | a substance that contains any quantity of a |
---|
25 | 25 | | derivative of barbituric acid, or any salt of a derivative of |
---|
26 | 26 | | barbituric acid not otherwise described by this subsection; |
---|
27 | 27 | | a compound, mixture, or preparation containing |
---|
28 | 28 | | amobarbital, secobarbital, pentobarbital, or any salt of any of |
---|
29 | 29 | | these, and one or more active medicinal ingredients that are not |
---|
30 | 30 | | listed in any penalty group; |
---|
31 | 31 | | a suppository dosage form containing amobarbital, |
---|
32 | 32 | | secobarbital, pentobarbital, or any salt of any of these drugs, and |
---|
33 | 33 | | approved by the United States Food and Drug Administration for |
---|
34 | 34 | | marketing only as a suppository; |
---|
35 | 35 | | Alprazolam; |
---|
36 | 36 | | Amobarbital; |
---|
37 | 37 | | Bromazepam; |
---|
38 | 38 | | Camazepam; |
---|
39 | 39 | | Chlordiazepoxide; |
---|
40 | 40 | | Chlorhexadol; |
---|
41 | 41 | | Clobazam; |
---|
42 | 42 | | Clonazepam; |
---|
43 | 43 | | Clorazepate; |
---|
44 | 44 | | Clotiazepam; |
---|
45 | 45 | | Cloxazolam; |
---|
46 | 46 | | Delorazepam; |
---|
47 | 47 | | Diazepam; |
---|
48 | 48 | | Estazolam; |
---|
49 | 49 | | Ethyl loflazepate; |
---|
50 | 50 | | Fludiazepam; |
---|
51 | 51 | | Flurazepam; |
---|
52 | 52 | | Glutethimide; |
---|
53 | 53 | | Halazepam; |
---|
54 | 54 | | Haloxzolam; |
---|
55 | 55 | | Ketazolam; |
---|
56 | 56 | | Loprazolam; |
---|
57 | 57 | | Lorazepam; |
---|
58 | 58 | | Lormetazepam; |
---|
59 | 59 | | Lysergic acid, including its salts, isomers, and |
---|
60 | 60 | | salts of isomers; |
---|
61 | 61 | | Lysergic acid amide, including its salts, |
---|
62 | 62 | | isomers, and salts of isomers; |
---|
63 | 63 | | Mebutamate; |
---|
64 | 64 | | Medazepam; |
---|
65 | 65 | | Methyprylon; |
---|
66 | 66 | | Midazolam; |
---|
67 | 67 | | Nimetazepam; |
---|
68 | 68 | | Nitrazepam; |
---|
69 | 69 | | Nordiazepam; |
---|
70 | 70 | | Oxazepam; |
---|
71 | 71 | | Oxazolam; |
---|
72 | 72 | | Pentazocine, its salts, derivatives, or compounds |
---|
73 | 73 | | or mixtures thereof; |
---|
74 | 74 | | Pentobarbital; |
---|
75 | 75 | | Pinazepam; |
---|
76 | 76 | | Prazepam; |
---|
77 | 77 | | Quazepam; |
---|
78 | 78 | | Secobarbital; |
---|
79 | 79 | | Sulfondiethylmethane; |
---|
80 | 80 | | Sulfonethylmethane; |
---|
81 | 81 | | Sulfonmethane; |
---|
82 | 82 | | Temazepam; |
---|
83 | 83 | | Tetrazepam; |
---|
84 | 84 | | Tiletamine and zolazepam in combination, and its |
---|
85 | 85 | | salts. (some trade or other names for a tiletamine-zolazepam |
---|
86 | 86 | | combination product: Telazol, for tiletamine: |
---|
87 | 87 | | 2-(ethylamino)-2-(2-thienyl)-cyclohexanone, and for zolazepam: |
---|
88 | 88 | | 4-(2-fluorophenyl)-6, |
---|
89 | 89 | | 8-dihydro-1,3,8,-trimethylpyrazolo-[3,4-e](1,4)-d |
---|
90 | 90 | | diazepin-7(1H)-one, flupyrazapon); |
---|
91 | 91 | | Triazolam; |
---|
92 | 92 | | Zaleplon; and |
---|
93 | 93 | | Zolpidem; |
---|
94 | 94 | | (3) Nalorphine; |
---|
95 | 95 | | (4) a material, compound, mixture, or preparation |
---|
96 | 96 | | containing limited quantities of the following narcotic drugs, or |
---|
97 | 97 | | any of their salts: |
---|
98 | 98 | | not more than 1.8 grams of codeine, or any of its |
---|
99 | 99 | | salts, per 100 milliliters or not more than 90 milligrams per dosage |
---|
100 | 100 | | unit, with an equal or greater quantity of an isoquinoline alkaloid |
---|
101 | 101 | | of opium; |
---|
102 | 102 | | not more than 1.8 grams of codeine, or any of its |
---|
103 | 103 | | salts, per 100 milliliters or not more than 90 milligrams per dosage |
---|
104 | 104 | | unit, with one or more active, nonnarcotic ingredients in |
---|
105 | 105 | | recognized therapeutic amounts; |
---|
106 | 106 | | not more than 300 milligrams of dihydrocodeinone |
---|
107 | 107 | | (hydrocodone), or any of its salts, per 100 milliliters or not more |
---|
108 | 108 | | than 15 milligrams per dosage unit, with a fourfold or greater |
---|
109 | 109 | | quantity of an isoquinoline alkaloid of opium; |
---|
110 | 110 | | not more than 300 milligrams of dihydrocodeinone |
---|
111 | 111 | | (hydrocodone), or any of its salts, per 100 milliliters or not more |
---|
112 | 112 | | than 15 milligrams per dosage unit, with one or more active, |
---|
113 | 113 | | nonnarcotic ingredients in recognized therapeutic amounts; |
---|
114 | 114 | | not more than 1.8 grams of dihydrocodeine, or any |
---|
115 | 115 | | of its salts, per 100 milliliters or not more than 90 milligrams per |
---|
116 | 116 | | dosage unit, with one or more active, nonnarcotic ingredients in |
---|
117 | 117 | | recognized therapeutic amounts; |
---|
118 | 118 | | not more than 300 milligrams of ethylmorphine, or |
---|
119 | 119 | | any of its salts, per 100 milliliters or not more than 15 milligrams |
---|
120 | 120 | | per dosage unit, with one or more active, nonnarcotic ingredients |
---|
121 | 121 | | in recognized therapeutic amounts; |
---|
122 | 122 | | not more than 500 milligrams of opium per 100 |
---|
123 | 123 | | milliliters or per 100 grams, or not more than 25 milligrams per |
---|
124 | 124 | | dosage unit, with one or more active, nonnarcotic ingredients in |
---|
125 | 125 | | recognized therapeutic amounts; |
---|
126 | 126 | | not more than 50 milligrams of morphine, or any of |
---|
127 | 127 | | its salts, per 100 milliliters or per 100 grams with one or more |
---|
128 | 128 | | active, nonnarcotic ingredients in recognized therapeutic amounts; |
---|
129 | 129 | | and |
---|
130 | 130 | | not more than 1 milligram of difenoxin and not |
---|
131 | 131 | | less than 25 micrograms of atropine sulfate per dosage unit; |
---|
132 | 132 | | (5) a material, compound, mixture, or preparation that |
---|
133 | 133 | | contains any quantity of the following substances: |
---|
134 | 134 | | Barbital; |
---|
135 | 135 | | Chloral betaine; |
---|
136 | 136 | | Chloral hydrate; |
---|
137 | 137 | | Ethchlorvynol; |
---|
138 | 138 | | Ethinamate; |
---|
139 | 139 | | Meprobamate; |
---|
140 | 140 | | Methohexital; |
---|
141 | 141 | | Methylphenobarbital (Mephobarbital); |
---|
142 | 142 | | Paraldehyde; |
---|
143 | 143 | | Petrichloral; and |
---|
144 | 144 | | Phenobarbital; |
---|
145 | 145 | | (6) Peyote, unless unharvested and growing in its |
---|
146 | 146 | | natural state, meaning all parts of the plant classified |
---|
147 | 147 | | botanically as Lophophora, whether growing or not, the seeds of the |
---|
148 | 148 | | plant, an extract from a part of the plant, and every compound, |
---|
149 | 149 | | manufacture, salt, derivative, mixture, or preparation of the |
---|
150 | 150 | | plant, its seeds, or extracts; |
---|
151 | 151 | | (7) unless listed in another penalty group, a |
---|
152 | 152 | | material, compound, mixture, or preparation that contains any |
---|
153 | 153 | | quantity of the following substances having a stimulant effect on |
---|
154 | 154 | | the central nervous system, including the substance's salts, |
---|
155 | 155 | | optical, position, or geometric isomers, and salts of the |
---|
156 | 156 | | substance's isomers, if the existence of the salts, isomers, and |
---|
157 | 157 | | salts of isomers is possible within the specific chemical |
---|
158 | 158 | | designation: |
---|
159 | 159 | | Benzphetamine; |
---|
160 | 160 | | Cathine [(+)-norpseudoephedrine]; |
---|
161 | 161 | | Chlorphentermine; |
---|
162 | 162 | | Clortermine; |
---|
163 | 163 | | Diethylpropion; |
---|
164 | 164 | | Fencamfamin; |
---|
165 | 165 | | Fenfluramine; |
---|
166 | 166 | | Fenproporex; |
---|
167 | 167 | | Mazindol; |
---|
168 | 168 | | Mefenorex; |
---|
169 | 169 | | Modafinil; |
---|
170 | 170 | | Pemoline (including organometallic complexes and |
---|
171 | 171 | | their chelates); |
---|
172 | 172 | | Phendimetrazine; |
---|
173 | 173 | | Phentermine; |
---|
174 | 174 | | Pipradrol; |
---|
175 | 175 | | Sibutramine; and |
---|
176 | 176 | | SPA [(-)-1-dimethylamino-1,2-diphenylethane]; |
---|
177 | 177 | | (8) unless specifically excepted or unless listed in |
---|
178 | 178 | | another penalty group, a material, compound, mixture, or |
---|
179 | 179 | | preparation that contains any quantity of the following substance, |
---|
180 | 180 | | including its salts: |
---|
181 | 181 | | Dextropropoxyphene (Alpha-(+)- |
---|
182 | 182 | | 4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane); [and] |
---|
183 | 183 | | (9) an anabolic steroid or any substance that is |
---|
184 | 184 | | chemically or pharmacologically related to testosterone, other |
---|
185 | 185 | | than an estrogen, progestin, or corticosteroid, and promotes muscle |
---|
186 | 186 | | growth, including: |
---|
187 | 187 | | Boldenone; |
---|
188 | 188 | | Chlorotestosterone (4-chlortestosterone); |
---|
189 | 189 | | Clostebol; |
---|
190 | 190 | | Dehydrochlormethyltestosterone; |
---|
191 | 191 | | Dihydrotestosterone (4-dihydrotestosterone); |
---|
192 | 192 | | Drostanolone; |
---|
193 | 193 | | Ethylestrenol; |
---|
194 | 194 | | Fluoxymesterone; |
---|
195 | 195 | | Formebulone; |
---|
196 | 196 | | Mesterolone; |
---|
197 | 197 | | Methandienone; |
---|
198 | 198 | | Methandranone; |
---|
199 | 199 | | Methandriol; |
---|
200 | 200 | | Methandrostenolone; |
---|
201 | 201 | | Methenolone; |
---|
202 | 202 | | Methyltestosterone; |
---|
203 | 203 | | Mibolerone; |
---|
204 | 204 | | Nandrolone; |
---|
205 | 205 | | Norethandrolone; |
---|
206 | 206 | | Oxandrolone; |
---|
207 | 207 | | Oxymesterone; |
---|
208 | 208 | | Oxymetholone; |
---|
209 | 209 | | Stanolone; |
---|
210 | 210 | | Stanozolol; |
---|
211 | 211 | | Testolactone; |
---|
212 | 212 | | Testosterone; and |
---|
213 | 213 | | Trenbolone; and |
---|
214 | 214 | | (10) Salvia divinorum, unless unharvested and growing |
---|
215 | 215 | | in its natural state, meaning all parts of that plant, whether |
---|
216 | 216 | | growing or not, the seeds of that plant, an extract from a part of |
---|
217 | 217 | | that plant, and every compound, manufacture, salt, derivative, |
---|
218 | 218 | | mixture, or preparation of that plant, its seeds, or extracts, |
---|
219 | 219 | | including Salvinorin A. |
---|
220 | 220 | | SECTION 2. This Act takes effect September 1, 2009. |
---|